Vir Biotechnology (VIR) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

VIR Vir Biotechnology

Watchlist

7.960
+0.100+1.27%

Close Nov 29 13:00 ET

8.380
+0.420+5.28%

Post 16:24 ET

1.10BMarket Cap-2025P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Vir Biotechnology to Host Virtual Investor Event on PRO-XTEN Masked T-Cell Engager Programs
Vir BiotechnologyNov 26 00:00 ET
Vir Biotechnology to Participate in the 7th Annual Evercore ISI HealthCONx Conference
Vir BiotechnologyNov 25 00:00 ET
Trump Nominates Marty Makary For FDA Commissioner
Barron'sNov 22 22:27 ET
J.P. Morgan Sticks to Their Hold Rating for Vir Biotechnology (VIR)
TipRanksNov 21 07:06 ET · Ratings
Leerink Partners Maintains Vir Biotechnology(VIR.US) With Buy Rating, Maintains Target Price $18
Moomoo NewsNov 21 01:31 ET · Ratings
Express News | HC Wainwright & Co. Reiterates Buy on Vir Biotechnology, Maintains $110 Price Target
BenzingaNov 20 10:01 ET

Comments

NoNo444

Nov 18 21:10

$Vir Biotechnology (VIR.US)$ The graph looks funny...

Jaguar8

Nov 18 21:06

ADDED NEWS

$Vir Biotechnology (VIR.US)$
Vir Biotechnology Presents Positive Chronic Hepatitis Delta Clinical Trial Data and Announces Initiation of Phase 3 Registrational Program
Phase 3 Eclipse Program to Evaluate Tobevibart and Elebsiran

Stock_Drift

Nov 18 20:25

$Vir Biotechnology (VIR.US)$

Trytosaveabit

Nov 18 15:07

Update

$Vir Biotechnology (VIR.US)$ Reuters· just
Vir Biotechnology Receives Positive Opinion on Orphan Drug Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta From European Medicines Agency